GABA B receptors in reward processes

Advances in Pharmacology

Volumn 58, Issue C, 2010, Pages 315-371

  Vlachou, Styliani ^a   Markou, Athina ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Addictive drugs; Reward processes

Indexed keywords

2 HYDROXYSACLOFEN; 2,6 DI TERT BUTYL 4 (3 HYDROXY 2,2 DIMETHYLPROPYL)PHENOL; 3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 3 AMINOPROPYL(METHYL)PHOSPHINIC ACID; 4 AMINO CYCLOPENT 2 ENE CARBOXYLIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; 5,5 DIMETHYL 2 MORPHOLINEACETIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; BACLOFEN; BHF 177; CGP 44532; CGP 51176; CGP 56433A; GABAPENTIN; KEMSTRO; METHAMPHETAMINE; MUSCIMOL; N,N' DICYCLOPENTYL 2 METHYLTHIO 5 NITRO 4,6 PYRIMIDINEDIAMINE; OXYBATE SODIUM; PHACLOFEN; TIAGABINE; UNCLASSIFIED DRUG; VIGABATRIN; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; STREET DRUG;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; BEHAVIOR CHANGE; BLURRED VISION; BRAIN REGION; COCAINE DEPENDENCE; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG ABUSE; DRUG ACTIVITY; DRUG DEPENDENCE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENCY; DRUG POTENTIATION; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; HEROIN DEPENDENCE; HUMAN; LOCOMOTION; LOW DRUG DOSE; MENTAL DISEASE; MORPHINE ADDICTION; MOTOR DYSFUNCTION; NAUSEA; NEUROTRANSMISSION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RELAPSE; REWARD; SEDATION; SIDE EFFECT; TOBACCO DEPENDENCE; TREATMENT RESPONSE; VISUAL FIELD CONSTRICTION; VISUAL FIELD DEFECT; WITHDRAWAL SYNDROME; ANIMAL; FOOD; METABOLISM; REVIEW; SELF STIMULATION;

ANIMALS; FOOD; GABA AGONISTS; HUMANS; RECEPTORS, GABA-B; REWARD; SELF STIMULATION; STREET DRUGS;

EID: 77955044675     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(10)58013-X     Document Type: Chapter

References (162)

1. B receptor. CNS Drug Reviews 2007, 13:308-316.
2. Addolorato G., Caputo F., Capristo E., et al. Ability of baclofen in reducing alcohol craving and intake: II-preliminary clinical evidence. Alcoholism, Clinical and Experimental Research 2000, 24:67-71.
3. Addolorato G., Caputo F., Capristo E., et al. Baclofen efficacy in reducing alcohol craving and intake: A preliminary double-blind randomized controlled study. Alcohol and Alcoholism 2002, 37:504-508.
4. Addolorato G., Caputo F., Capristo E., et al. Rapid suppression of alcohol withdrawal syndrome by baclofen. American Journal of Medicine 2002, 112:226-229.
5. Addolorato G., Leggio L., Abenavoli L., et al. Suppression of alcohol delirium tremens by baclofen administration: A case report. Clinical Neuropharmacology 2003, 26:258-262.
6. Addolorato G., Leggio L., Abenavoli L., et al. Baclofen in the treatment of alcohol withdrawal syndrome: A comparative study vs diazepam. American Journal of Medicine 2006, 119. 276e13-276e18.
7. Addolorato G., Leggio L., Agabio R., et al. Baclofen: A new drug for the treatment of alcohol dependence. International Journal of Clinical Practice 2006, 60:1003-1008.
8. B receptor system in alcoholism and stress: Focus on clinical studies and treatment perspectives. Alcohol 2009, 43:559-563.
9. Addolorato G., Leggio L., Ferrulli A., et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: Randomised, double-blind controlled study. Lancet 2007, 370:1915-1922.
10. Agabio R., Marras P., Addolorato G., et al. Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient: A case report. Journal of Clinical Psychopharmacology 2007, 27:319-320.
11. Ameisen O. Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: A self-case report of a physician. Alcohol and Alcoholism 2005, 40:147-150.
12. Anstrom K.K., Cromwell H.C., Markowski T., et al. Effect of baclofen on alcohol and sucrose self-administration in rats. Alcoholism, Clinical and Experimental Research 2003, 27:900-908.
13. Ascaso F.J., Lopez M.J., Mauri J.A., et al. Visual field defects in pediatric patients on vigabatrin monotherapy. Documenta Ophthalmologica 2003, 107:127-130.
14. Ashby C.R., Paul M., Gardner E.L., et al. Systemic administration of 1r,4s-4-amino-cyclopent-2-ene-carboxylic acid, a reversible inhibitor of GABA transaminase, blocks expression of conditioned place preference to cocaine and nicotine in rats. Synapse 2002, 44:61-63.
15. B receptor in gamma vinyl-GABA's inhibition of cocaine-induced increases in nucleus accumbens dopamine. Synapse 1999, 31:151-153.
16. Barrett A.C., Negus S.S., Mello N.K., et al. Effect of GABA agonists and GABA-A receptor modulators on cocaine- and food-maintained responding and cocaine discrimination in rats. Journal of Pharmacology and Experimental Therapeutics 2005, 315:858-871.
17. Bechtholt A.J., Cunningham C.L. Ethanol-induced conditioned place preference is expressed through a ventral tegmental area dependent mechanism. Behavioral Neuroscience 2005, 119:213-223.
18. B receptor agonists reduce operant ethanol self-administration and enhance ethanol sedation in C57BL/6j mice. Psychopharmacology 2004, 174:358-366.
19. B sites. Neuropharmacology 1985, 24:207-210.
20. Brebner K., Ahn S., Phillips A.G. Attenuation of d-amphetamine self-administration by baclofen in the rat: Behavioral and neurochemical correlates. Psychopharmacology 2005, 177:409-417.
21. B agonists in the treatment of psychostimulant addiction. Alcohol and Alcoholism 2002, 37:478-484.
22. B agonist CGP 44532 decreases cocaine self-administration in rats: Demonstration using a progressive ratio and a discrete trials procedure. Neuropharmacology 1999, 38:1797-1804.
23. B antagonist CGP56433A attenuates the effect of baclofen on cocaine but not heroin self-administration in the rat. Psychopharmacology 2002, 160:49-55.
24. Brebner K., Phelan R., Roberts D.C.S. Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules. Psychopharmacology 2000, 148:314-321.
25. Brebner K., Phelan R., Roberts D.C.S. Intra-VTA baclofen attenuates cocaine self-administration on a progressive ratio schedule of reinforcement. Pharmacology Biochemistry and Behavior 2000, 66:857-862.
26. Brodie J.D., Figueroa E., Laska E.M., et al. Safety and efficacy of γ-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction. Synapse 2005, 55:122-125.
27. Bucknam W. Suppression of symptoms of alcohol dependence and craving using high-dose baclofen. Alcohol and Alcoholism 2007, 42:158-160.
28. Campbell U.C., Lac S.T., Carroll M.E. Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats. Psychopharmacology 1999, 143:209-214.
29. Christopoulos A. Allosteric binding sites on cell-surface receptors: Novel targets for drug discovery. Nature reviews. Drug discovery 2002, 1:198-210.
30. Colombo G., Agabio R., Carai M.A., et al. Ability of baclofen in reducing alcohol intake and withdrawal severity: I-preclinical evidence. Alcoholism, Clinical and Experimental Research 2000, 24:58-66.
31. B receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats. Alcohol and Alcoholism 2002, 37:499-503.
32. Colombo G., Serra S., Brunetti G., et al. Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats. Drug and Alcohol Dependence 2003, 70:105-108.
33. Colombo G., Serra S., Vacca G., et al. Suppression by baclofen of the stimulation of alcohol intake induced by morphine and WIN 55,212-2 in alcohol-preferring rats. European Journal of Pharmacology 2004, 492:189-193.
34. Colombo G., Serra S., Vacca G., et al. Baclofen-induced suppression of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats exposed to different alcohol concentrations. European Journal of Pharmacology 2006, 550:123-126.
35. Colombo G., Vacca G., Serra S., et al. Baclofen suppresses motivation to consume alcohol in rats. Psychopharmacology 2003, 167:221-224.
36. Conn P.J., Christopoulos A., Lindsley C.W. Allosteric modulators of GPCRs: A novel approach for the treatment of CNS disorders. Nature reviews. Drug discovery 2009, 8:41-54.
37. Corrigall W.A., Coen K.M., Adamson K.L., et al. Response of nicotine self-administration in the rat to manipulations of mu-opioid and γ-aminobutyric acid receptors in the ventral tegmental area. Psychopharmacology 2000, 149:107-114.
38. Corrigall W.A., Coen K.M., Zhang J., et al. GABA mechanisms in the pedunculopontine tegmental nucleus influence particular aspects of nicotine self-administration selectively in the rat. Psychopharmacology 2001, 158:190-197.
39. Cousins M.S., Stamat H.M., de Wit H. Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking. Nicotine & Tobacco Research 2001, 3:123-129.
40. B receptor-positive modulator GS39783 (N,n'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. Journal of Pharmacology and Experimental Therapeutics 2004, 310:952-963.
41. Daoust M., Saligaut C., Lhuintre J.P., et al. GABA transmission, but not benzodiazepine receptor stimulation, modulates ethanol intake by rats. Alcohol 1987, 4:469-472.
42. DeMarco A., Dalal R.M., Pai J., et al. Racemic gamma vinyl-GABA (R,S-GVG) blocks methamphetamine-triggered reinstatement of conditioned place preference. Synapse 2009, 63:87-94.
43. B receptors in the basal forebrain selectively impairs working memory of rats in the double Y-maze. Brain Research 1994, 641:29-38.
44. Dewey S.L., Brodie J.D., Gerasimov M., et al. A pharmacologic strategy for the treatment of nicotine addiction. Synapse 1999, 31:76-86.
45. Dewey S.L., Morgan A.E., Ashby C.R., et al. A novel strategy for the treatment of cocaine addiction. Synapse 1998, 30:119-129.
46. 11 C-raclopride and positron emission tomography. Journal of Neuroscience 1992, 12:3773-3780.
47. Di Ciano P., Everitt B.J. Reinstatement and spontaneous recovery of cocaine-seeking following extinction and different durations of withdrawal. Behavioural Pharmacology 2002, 13:397-405.
48. Diaz S.L., Barros V.G., Antonelli M.C., et al. Morphine withdrawal syndrome and its prevention with baclofen: Autoradiographic study of γ-opioid receptors in prepubertal male and female mice. Synapse 2006, 60:132-140.
49. Diaz S.L., Kemmling A.K., Rubio M.C., et al. Lack of sex-related differences in the prevention by baclofen of the morphine withdrawal syndrome in mice. Behavioural Pharmacology 2001, 12:75-79.
50. B receptor agonist, is hedonically neutral and reduces cocaine-induced enhancement of reward. Neuropharmacology 2002, 42:626-632.
51. B -receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigra. Synapse 1993, 15:229-238.
52. Epstein D.H., Preston K.L., Stewart J., et al. Toward a model of drug relapse: An assessment of the validity of the reinstatement procedure. Psychopharmacology 2006, 189:1-16.
53. Evans S.M., Bisaga A. Acute interaction of baclofen in combination with alcohol in heavy social drinkers. Alcoholism, Clinical and Experimental Research 2009, 33:19-30.
54. Everitt B.J., Belin D., Economidou D., et al. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 2008, 363:3125-3135.
55. Fadda P., Scherma M., Fresu A., et al. Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat. Synapse 2003, 50:1-6.
56. Fallon J.H., Koziell D.A., Moore R.Y. Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex. Journal of Comparative Neurology 1978, 180:509-532.
57. Fallon J.H., Moore R.Y. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. Journal of Comparative Neurology 1978, 180:545-580.
58. Fattore L., Cossu G., Martellotta M.C., et al. Baclofen antagonizes intravenous self-administration of nicotine in mice and rats. Alcohol and Alcoholism 2002, 37:495-498.
59. Fattore L., Spano M.S., Cossu G., et al. Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents. European Neuropsychopharmacology 2009, 19:487-498.
60. Feltenstein M.W., See R.E. The neurocircuitry of addiction: An overview. British Journal of Pharmacology 2008, 154:261-274.
61. Fenton H.M., Liebman J.M. Self-stimulation response decrement patterns differentiate clonidine, baclofen and dopamine antagonists from drugs causing performance deficit. Pharmacology Biochemistry and Behavior 1982, 17:1207-1212.
62. B receptor agents on cocaine priming, discrete contextual cue and food induced relapses. European Journal of Pharmacology 2007, 571:166-173.
63. B receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination. European Journal of Pharmacology 2007, 574:148-157.
64. Filip M., Frankowska M., Zaniewska M., et al. Diverse effects of GABA-mimetic drugs on cocaine-evoked self-administration and discriminative stimulus effects in rats. Psychopharmacology 2007, 192:17-26.
65. Flannery B.A., Garbutt J.C., Cody M.W., et al. Baclofen for alcohol dependence: A preliminary open-label study. Alcoholism, Clinical and Experimental Research 2004, 28:1517-1523.
66. B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study. Drug and Alcohol Dependence 2009, 103:30-36.
67. B receptor ligands on the immobility, swimming and climbing in the forced swim test in rats following discontinuation of cocaine self-administration. European Journal of Pharmacology 2010, 627:142-149.
68. B agonists. Journal of Medicinal Chemistry 1995, 38:3297-3312.
69. B antagonists. Journal of Medicinal Chemistry 1995, 38:3313-3331.
70. Gerasimov M.R., Ashby C.R., Gardner E.L., et al. γ-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine. Synapse 1999, 34:11-19.
71. Gerasimov M.R., Dewey S.L. Gamma-vinyl γ-aminobutyric acid attenuates the synergistic elevations of nucleus accumbens dopamine produced by a cocaine/heroin (speedball) challenge. European Journal of Pharmacology 1999, 380:1-4.
72. Gerasimov M.R., Schiffer W.K., Gardner E.L., et al. GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamine. European Journal of Pharmacology 2001, 414:205-209.
73. Heimer L., Zahm D.S., Churchill L., et al. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 1991, 41:89-125.
74. Hernandez G., Hamdani S., Rajabi H., et al. Prolonged rewarding stimulation of the rat medial forebrain bundle: Neurochemical and behavioral consequences. Behavioral Neuroscience 2006, 120:888-904.
75. B ligands on alcohol withdrawal in mice. Pharmacology Biochemistry and Behavior 1994, 49:561-566.
76. Jung M.J., Lippert B., Metcalf B.W., et al. γ-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: Effects on brain GABA metabolism in mice. Journal of neurochemistry 1977, 29:797-802.
77. Kahn R., Biswas K., Childress A.R., et al. Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals. Drug and Alcohol Dependence 2009, 103:59-64.
78. Kalivas P.W. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Research. Brain Research Reviews 1993, 18:75-113.
79. Kalivas P.W., Striplin C.D., Steketee J.D., et al. Cellular mechanisms of behavioral sensitization to drugs of abuse. Annals of the New York Academy of Sciences 1992, 654:128-135.
80. Kalivas P.W., Volkow N.D. The neural basis of addiction: A pathology of motivation and choice. American Journal of Psychiatry 2005, 162:1403-1413.
81. Kaplan G.B., Leite-Morris K.A., Joshi M., et al. Baclofen inhibits opiate-induced conditioned place preference and associated induction of fos in cortical and limbic regions. Brain Research 2003, 987:122-125.
82. Kemmling A.K., Rubio M.C., Balerio G.N. Baclofen prevents morphine withdrawal irrespective of seasonal variation. Behavioural Pharmacology 2002, 13:87-92.
83. Klitenick M.A., DeWitte P., Kalivas P.W. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: An in vivo microdialysis study. Journal of Neuroscience 1992, 12:2623-2632.
84. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
85. Kushner S.A., Dewey S.L., Kornetsky C. γ-Vinyl GABA attenuates cocaine-induced lowering of brain stimulation reward thresholds. Psychopharmacology 1997, 133:383-388.
86. Kushner S.A., Dewey S.L., Kornetsky C. The irreversible γ-aminobutyric acid (GABA) transaminase inhibitor γ-vinyl-GABA blocks cocaine self-administration in rats. Journal of Pharmacology and Experimental Therapeutics 1999, 290:797-802.
87. Le Foll B., Wertheim C.E., Goldberg S.R. Effects of baclofen on conditioned rewarding and discriminative stimulus effects of nicotine in rats. Neuroscience Letters 2008, 443:236-240.
88. Leggio L., Ferrulli A., Cardone S., et al. Relationship between the hypothalamic-pituitary-thyroid axis and alcohol craving in alcohol-dependent patients: A longitudinal study. Alcoholism, Clinical and Experimental Research 2008, 32:2047-2053.
89. Leggio L., Garbutt J.C., Addolorato G. Effectiveness and safety of baclofen in the treatment of alcohol dependent patients. CNS & Neurological Disorders Drug Targets 2010, 9:33-44.
90. B receptor agonist baclofen attenuates the development and expression of d-methamphetamine-induced place preference in rats. Life Sciences 2001, 70:349-356.
91. B receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats. Neuropharmacology 2006, 50:632-639.
92. Ling W., Shoptaw S., Majewska D. Baclofen as a cocaine anti-craving medication: A preliminary clinical study. Neuropsychopharmacology 1998, 18:403-404.
93. Maccioni P., Bienkowski P., Carai M.A., et al. Baclofen attenuates cue-induced reinstatement of alcohol-seeking behavior in Sardinian alcohol-preferring (sP) rats. Drug and Alcohol Dependence 2008, 95:284-287.
94. B receptor, BHF177, in alcohol-preferring rats. Alcoholism, Clinical and Experimental Research 2009, 33:1749-1756.
95. B receptor in alcohol-seeking and drinking behavior. Alcohol 2009, 43:555-558.
96. B receptor direct agonist, baclofen. Alcoholism, Clinical and Experimental Research 2008, 32:1558-1564.
97. Maccioni P., Pes D., Fantini N., et al. γ-Hydroxybutyric acid (GHB) suppresses alcohol's motivational properties in alcohol-preferring rats. Alcohol 2008, 42:107-113.
98. B receptor, GS39783, on alcohol self-administration in alcohol-preferring rats. Psychopharmacology 2007, 193:171-178.
99. Maccioni P., Serra S., Vacca G., et al. Baclofen-induced reduction of alcohol reinforcement in alcohol-preferring rats. Alcohol 2005, 36:161-168.
100. B receptor, rac-BHFF, suppresses alcohol self-administration. Drug and Alcohol Dependence 2010, 109:96-103.
101. B receptor agonist and antagonists decreased brain stimulation reward in the rat. Neuropharmacology 2001, 40:676-685.
102. B receptors. British Journal of Pharmacology 2008, 154:797-811.
103. B receptor agonist, dose-dependently impairs spatial learning in rats. Pharmacology Biochemistry and Behavior 1996, 53:303-308.
104. B receptors make it to the top - as dimers. Trends in Pharmacological Sciences 1999, 20:87-89.
105. Molina P.E., Ahmed N., Ajmal M., et al. Co-administration of γ-vinyl GABA and cocaine: Preclinical assessment of safety. Life Sciences 1999, 65:1175-1182.
106. B receptor-positive modulation-induced blockade of the rewarding properties of nicotine is associated with a reduction in nucleus accumbens ΔFosB accumulation. Journal of Pharmacology and Experimental Therapeutics 2007, 321:172-177.
107. Nestler E.J. Is there a common molecular pathway for addiction?. Nature Neuroscience 2005, 8:1445-1449.
108. Nestler E.J. Transcriptional mechanisms of addiction: Role of ΔFosB. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 2008, 363:3245-3255.
109. B receptor modulators. CNS Drug Reviews 2005, 11:317-334.
110. B receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats. European Journal of Pharmacology 2005, 525:105-111.
111. B , NMDA and AMPA receptor agonists on ventral pallidum self-stimulation. Behavioural Brain Research 2002, 131:115-123.
112. B receptor-mediated regulation of brain reward function. Neuropharmacology 2005, 49:953-962.
113. B receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology 2004, 172:179-186.
114. B receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats. Neuropsychopharmacology 2005, 30:119-128.
115. Paterson N.E., Markou A. Increased GABA neurotransmission via administration of γ-vinyl GABA decreased nicotine self-administration in the rat. Synapse 2002, 44:252-253.
116. B receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats. Journal of Pharmacology and Experimental Therapeutics 2008, 326:306-314.
117. Paul M., Dewey S.L., Gardner E.L., et al. γ-Vinyl GABA (GVG) blocks expression of the conditioned place preference response to heroin in rats. Synapse 2001, 41:219-220.
118. Ranaldi R., Poeggel K. Baclofen decreases methamphetamine self-administration in rats. NeuroReport 2002, 13:1107-1110.
119. B receptor agonist in the locus coeruleus of rats. Behavioural Brain Research 2009, 196:11-14.
120. B agonists as a pharmacotherapy for cocaine addiction. Physiology & Behavior 2005, 86:18-20.
121. Roberts D.C.S., Andrews M.M. Baclofen suppression of cocaine self-administration: Demonstration using a discrete trials procedure. Psychopharmacology 1997, 131:271-277.
122. Roberts D.C.S., Andrews M.M., Vickers G.J. Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacology 1996, 15:417-423.
123. Roberts D.C.S., Brebner K. GABA modulation of cocaine self-administration. Annals of the New York Academy of Sciences 2000, 909:145-158.
124. B receptors within the ventral tegmental area are involved in the expression and acquisition of morphine-induced place preference in morphine-sensitized rats. Pharmacology Biochemistry and Behavior 2009, 91:409-416.
125. Schiffer W.K., Gerasimov M.R., Bermel R.A., et al. Stereoselective inhibition of dopaminergic activity by gamma vinyl-GABA following a nicotine or cocaine challenge: A PET/microdialysis study. Life Sciences 2000, 66:PL169-PL173.
126. Schmidt H.D., Anderson S.M., Famous K.R., et al. Anatomy and pharmacology of cocaine priming-induced reinstatement of drug seeking. European Journal of Pharmacology 2005, 526:65-76.
127. Schmitz B., Schmidt T., Jokiel B., et al. Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs: A prospective study. Journal of Neurology 2002, 249:469-475.
128. Schultz W. Reward signaling by dopamine neurons. Neuroscientist 2001, 7:293-302.
129. Schultz W. Multiple dopamine functions at different time courses. Annual Review of Neuroscience 2007, 30:259-288.
130. See R.E. Neural substrates of cocaine-cue associations that trigger relapse. European Journal of Pharmacology 2005, 526:140-146.
131. B receptor agonist baclofen administered into the median and dorsal raphe nuclei is rewarding as shown by intracranial self-administration and conditioned place preference in rats. Psychopharmacology 2010, in press.
132. B agonist baclofen modifies cocaine self-administration in rats. Behavioural Pharmacology 1998, 9:195-206.
133. Shoptaw S., Yang X., Rotheram-Fuller E.J., et al. Randomized placebo-controlled trial of baclofen for cocaine dependence: Preliminary effects for individuals with chronic patterns of cocaine use. Journal of Clinical Psychiatry 2003, 64:1440-1448.
134. B receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: Intracranial self-stimulation studies in the rat. Neuropsychopharmacology 2005, 30:2065-2072.
135. B receptor on cocaine self-administration in rats. Psychopharmacology 2004, 173:105-111.
136. B receptor agonist baclofen prevents heroin-induced reinstatement of heroin-seeking behavior in rats. Neuropharmacology 2007, 52:1555-1562.
137. B receptors originate from discrete afferent neurons. Neuroscience Letters 1992, 134:207-211.
138. B receptor agonist baclofen on the γ-opioid receptor agonist-induced antinociceptive, emetic and rewarding effects. Neuropharmacology 2005, 49:1121-1131.
139. Takada K., Yanagita T. Drug dependence study on vigabatrin in rhesus monkeys and rats. Arzneimittel-Forschung 1997, 47:1087-1092.
140. Tobler P.N., Fiorillo C.D., Schultz W. Adaptive coding of reward value by dopamine neurons. Science 2005, 307:1642-1645.
141. B receptors inhibits morphine-induced place preference in rats. European Journal of Pharmacology 1996, 313:169-173.
142. B receptors by 2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Molecular Pharmacology 2001, 60:963-971.
143. B receptor function. Journal of Pharmacology and Experimental Therapeutics 2003, 307:322-330.
144. Vlachou S., Markou A. The use of the intracranial self-stimulation in drug abuse research: Addictive drugs and the neurobiology of reward and motivation. Animal models of drug addiction 2010, Springer, New York, in press. M.C. Olmstead (Ed.).
145. Walaas I., Fonnum F. The distribution and origin of glutamate decarboxylase and choline acetyltransferase in ventral pallidum and other basal forebrain regions. Brain Research 1979, 177:325-336.
146. Walaas I., Fonnum F. Biochemical evidence for γ-aminobutyrate containing fibres from the nucleus accumbens to the substantia nigra and ventral tegmental area in the rat. Neuroscience 1980, 5:63-72.
147. Walker B.M., Koob G.F. The γ-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats. Alcoholism, Clinical and Experimental Research 2007, 31:11-18.
148. B receptor agonists baclofen and CGP44532 but not the GABA reuptake inhibitor tiagabine in baboons. Drug and Alcohol Dependence 2007, 89:206-213.
149. Weiss F. Neurobiology of craving, conditioned reward and relapse. Current Opinion in Pharmacology 2005, 5:9-19.
150. B receptor. Nature 1998, 396:679-682.
151. B and NMDA receptor agonists on medial forebrain bundle self-stimulation. Behavioural Brain Research 1995, 70:31-36.
152. B receptors in midbrain monoamine containing neurons in the rat. Brain Research Bulletin 2001, 56:1-5.
153. Wohlrab G., Boltshauser E., Schmitt B., et al. Visual field constriction is not limited to children treated with vigabatrin. Neuropediatrics 1999, 30:130-132.
154. A receptors - an in vivo electrochemical study. Brain Research 1998, 798:156-165.
155. Xi Z.X., Stein E.A. Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. Journal of Pharmacology and Experimental Therapeutics 1999, 290:1369-1374.
156. Xi Z.X., Stein E.A. Increased mesolimbic GABA concentration blocks heroin self-administration in the rat. Journal of Pharmacology and Experimental Therapeutics 2000, 294:613-619.
157. Xi Z.X., Stein E.A. GABAergic mechanisms of opiate reinforcement. Alcohol and Alcoholism 2002, 37:485-494.
158. Xi Z.X., Wu G., Stein E.A., et al. GABAergic mechanisms of heroin-induced brain activation assessed with functional MRI. Magnetic Resonance in Medicine 2002, 48:838-843.
159. Yim C.Y., Mogenson G.J. Effect of picrotoxin and nipecotic acid on inhibitory response of dopaminergic neurons in the ventral tegmental area to stimulation of the nucleus accumbens. Brain Research 1980, 199:466-473.
160. Yim C.Y., Mogenson G.J. Electrophysiological studies of neurons in the ventral tegmental area of Tsai. Bain Research 1980, 181:301-313.
161. Yin H.H., Ostlund S.B., Knowlton B.J., et al. The role of the dorsomedial striatum in instrumental conditioning. European Journal of Neuroscience 2005, 22:513-523.
162. B receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats. Physiology & Behavior 2006, 87:31-38.